UK reaffirms commitment to 'a competitive service for clinical trial assessment' post Brexit

UK reaffirms commitment to 'a competitive service for clinical trial assessment' post Brexit

The UK government earlier this year​ provided the “strongest possible reassurance” that it will implement the incoming European Union Clinical Trials Regulation​, regardless of happens in the Brexit negotiations, during a discussion in the House of Lords​. Recently, the Medicines and Healthcare products Regulatory Agency (MHRA​) published an update​, detailing how the implementation period affects […]

Corporate Reputation of Pharma, 2017-2018 – The Patient Perspective of 169 US Patients – ResearchAndMarkets.com

Corporate Reputation of Pharma, 2017-2018 – The Patient Perspective of 169 US Patients – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–Aug 15, 2018–The “The Corporate Reputation of Pharma, 2017 – The Patient Perspective – US Edition” report has been added to ResearchAndMarkets.com‘s offering. US patient groups are traditionally more sceptical and suspicious of pharma than their peers in most of the rest of the world – which makes the 2017 US Corporate Reputation results […]

Breakfast With a Dose of Roundup?

Breakfast With a Dose of Roundup?

Weed Killer in $289 Million Cancer Verdict Found in Oat Cereal and Granola Bars WEDNESDAY, AUGUST 15, 2018 By Alexis Temkin, Ph.D., Toxicologist Report by the numbers Conventional Organic Samples Tested 45 16 Glyphosate Detects 43 5 Detects Above EWG’s Health Benchmark (160 ppb) 31 0 Popular oat cereals, oatmeal, granola and snack bars come […]

Morning Break: Monthly HIV Tx Effective; Curing Hemophilia; Elephants and Cancer

Morning Break: Monthly HIV Tx Effective; Curing Hemophilia; Elephants and Cancer

Note that some links may require subscriptions. GlaxoSmithKline’s Viiv Healthcare unit said its once-a-month injectable treatment for HIV was non-inferior to a standard daily three-drug oral regimen in a 48-week phase III trial. New York joins the parade of states suing OxyContin maker Purdue Pharma. (Reuters) And speaking of lawsuits, advocacy groups are suing over […]

Genprex secures more capital to bring Oncoprex to market

Genprex secures more capital to bring Oncoprex to market

Genprex Inc () said it has secured US$10mln in added capital which would be vital in bringing its lead lung cancer drug Oncoprex to market. Genprex Chairman and CEO Rodney Varner said in a statement that the US$10mln raised in the second quarter “provides additional financial resources to position the company to achieve […]

Precision Innovation Network builds cloud-based, AI-powered precision medicine app

Precision Innovation Network builds cloud-based, AI-powered precision medicine app

Growth of the artificial intelligence market for healthcare is expected to reach $6.6 billion by 2021, according to Accenture, and the combined deployment of key clinical health AI applications could potentially create $150 billion in annual savings for the U.S. healthcare economy by 2026. In line with that growing trend, Rockville Centre, New York-based Precision […]

Aging Data: Study Highlights Delays From Time of Clinical Trial Enrollment to Publication

Aging Data: Study Highlights Delays From Time of Clinical Trial Enrollment to Publication

If researchers running clinical trials thought more like patients, they might be more motivated to get results analyzed and published, one expert says. The average age of data among randomized clinical trials published in six high-impact medical journals in 2015 was 3 years, according to a new analysis. Substantial delays were identified during the enrollment […]

Merck, GSK and Pew Comment on Draft Guidance on LPAD Approval Pathway

Merck, GSK and Pew Comment on Draft Guidance on LPAD Approval Pathway

Merck, GlaxoSmithKline, BIO and Pew Charitable Trusts weighed in on recent draft guidance on the establishment of a limited population pathway for antibacterial and antifungal drugs (LPAD pathway). The draft is intended to assist sponsors in the development of certain new antibacterial and antifungal drugs for approval under the LPAD pathway, which was created under […]